Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Commercial laboratory Quest Diagnostics Inc. sees a growing direct-to-consumer testing opportunity following the Covid-19 pandemic, as patients seek greater control of their health care and the crisis ...

Coronavirus testing delays at Quest Diagnostics, a leading diagnostic information services company, decreased in August as compared to last month, when patients had to wait up to two weeks for results ...

With demand for COVID-19 tests rapidly drying up, testmakers like Quest Diagnostics are scrambling to find deeper waters that’ll keep them from running aground. Quest, for one, is banking on its core ...

LOS ANGELES (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for distribution to ...

Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early ...